Sanofi reports positive top-line results from first Phase 3 Study of Alemtuzumab (Lemtrada™)
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
List view / Grid view
News
Sanofi Divests Dermik Dermatology Unit to Valeant
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
Phase III trial of Novartis drug Afinitor® met primary endpoint of reducing SEGA tumor size in patients with tuberous sclerosis
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
Sanofi provides Multaq® Phase IIIb PALLAS trial update
7 July 2011 | By Sanofi
Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial...
Pharminox completes £1.5m funding round to progress development of novel anti-cancer drug candidates
7 July 2011 | By Citigate Dewe Rogerson
Pharminox has completed a new round of equity funding, raising approximately £1.5m...
Sage-N Research signs agreement with the U.S. Army ECBC
7 July 2011 | By The Scott Partnership
Sage-N, entered into an exclusive license agreement with the U.S. Army ECBC to commercialize a revolutionary new platform...
Novozymes Biopharma to present latest advances in drug delivery technology at Controlled Release Society Meeting
6 July 2011 | By The Scott Partnership
Two new scientific posters to be presented at the 2011 CRS meeting...
Boehringer Ingelheim and Ashoka’s Changemakers launch “Making More Health” competition
6 July 2011 | By Boehringer Ingelheim
The www.changemakers.com/morehealth competition launched...
Wyatt Technology’s Möbius Mobility Instrument Facilitates Protein Net Charge Computation at Low Concentrations
5 July 2011 | By The Scott Partnership
Möbius electrophoretic mobility instrument can measure precise protein charges...
Amgen and UCB team up With NASA
5 July 2011 | By Amgen
Amgen and UCB announced that they are collaborating with the NASA Ames Research Center to conduct a preclinical test...
Positive top-line results for Pfizer’s Lyrica in Phase 3 Study of patients with Fibromyalgia in Japan
5 July 2011 | By Pfizer
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208...
Novartis drug Afinitor® met primary endpoint of Phase III study
5 July 2011 | By Novartis AG
Afinitor® in combination with exemestane extended progression-free survival in women with advanced breast cancer...
London 2012 partner, GlaxoSmithKline, shares scientific expertise with WADA to help fight against abuse of drugs in sport
4 July 2011 | By GlaxoSmithKline
GlaxoSmithKline signed a long-term agreement with the World Anti-Doping Agency...
Pfizer affirms CHANTIX/CHAMPIX as important treatment option for smokers wanting to quit
4 July 2011 | By Pfizer
An effective and appropriate treatment option for adult smokers wanting to quit...
Biogen Idec researchers identify novel approach for promoting Remyelination
3 July 2011 | By Biogen Idec
Results from a study that suggest that inhibiting death receptor-6 (DR6) function may represent a novel approach...
